TX200-TR101
TX200-KT03
Phase 3 small_molecule active
Quick answer
TX200-TR101 for Kidney Transplant Rejection is a Phase 3 program (small_molecule) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- Kidney Transplant Rejection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active